DDrare: Database of Drug Development for Rare Diseases

Thymosin beta 4 (DrugBank: Thymosin beta 4)

2 diseases

ID	Disease name (Link within this page)	Number of trials
36	Epidermolysis bullosa	1
53	Sjogren syndrome	1

36. Epidermolysis bullosa [ 147 clinical trials, 170 drugs, (DrugBank: 40 drugs), 32 drug target genes, 113 drug target pathways]

Searched query = "Epidermolysis bullosa", "EBS", "JEB", "DDEB", "RDEB", "Kindler syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 147 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00311766 (ClinicalTrials.gov)	February 2006	4/4/2006	A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa	A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa	Epidermolysis Bullosa	Drug: Thymosin Beta 4;Drug: Placebo	RegeneRx Biopharmaceuticals, Inc.	NULL	Terminated	2 Years	N/A	All	30	Phase 2	United States

53. Sjogren syndrome [ 234 clinical trials, 270 drugs, (DrugBank: 85 drugs), 49 drug target genes, 174 drug target pathways]

Searched query = "Sjogren syndrome", "Sjögren syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01393132 (ClinicalTrials.gov)	March 2011	7/7/2011	Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye	Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye	Dry Eye;Sjogren's Syndrome;Graft vs. Host Disease	Drug: Thymosin Beta 4 eye drops;Drug: Vehicle Control	Michigan Cornea Consultants, PC	Kresge Eye Institute	Completed	18 Years	90 Years	All	9	Phase 2	United States